Lemierre's syndrome: An unusual presentation

Med Mal Infect. 2015 Aug;45(8):328-30. doi: 10.1016/j.medmal.2015.05.009. Epub 2015 Jun 24.

Authors

F Medina¹, M Tatay², M Smati³, O Aoun⁴, J Tankovic⁵, O Bouchaud², F Méchaï²

Affiliations

¹ Bacteriology department, CHU Avicenne, 125, rue de Stalingrad, 93000 Bobigny, France. Electronic address: [email protected].
² Infectious diseases unit, CHU Avicenne, 93000 Bobigny, France.
³ UMR 722, Inserm, Paris, France.
⁴ Armed forces medical center, Colmar, France.
⁵ Microbiology department, CHU Saint-Antoine, 75012 Paris, France.

PMID: 26117663
DOI: 10.1016/j.medmal.2015.05.009

No abstract available

Keywords: Embole septique; Lemierre syndrome; Parvimonas micra; Septic embolism; Spondylite; Spondylitis; Syndrome de Lemierre.

Publication types

Case Reports

MeSH terms

Amoxicillin-Potassium Clavulanate Combination / therapeutic use
Anti-Bacterial Agents / therapeutic use
Cervical Vertebrae / microbiology*
Clindamycin / therapeutic use
Drug Therapy, Combination
Embolism / diagnostic imaging
Embolism / etiology
Female
Gram-Positive Bacterial Infections / complications*
Gram-Positive Bacterial Infections / drug therapy
Gram-Positive Bacterial Infections / microbiology
Headache / etiology
Humans
Lemierre Syndrome / complications
Lemierre Syndrome / diagnosis*
Lemierre Syndrome / microbiology
Myalgia / etiology
Peptostreptococcus / isolation & purification*
Retropharyngeal Abscess / etiology
Rifampin / therapeutic use
Spondylitis / diagnostic imaging
Spondylitis / drug therapy
Spondylitis / etiology*
Tomography, X-Ray Computed
Young Adult

Substances

Anti-Bacterial Agents
Clindamycin
Amoxicillin-Potassium Clavulanate Combination
Rifampin